Posted in | News

Axion and Coll Materials Increase Production Capabilities to Meet Demand for ECOTRAX Rail Ties

Axion International declared that it has witnessed a considerable growth in its production capabilities.

The company specializes in developing Coll Materials, STRUXURE industrial building materials and Recycled Structural Composite (RSC) technology that facilitate the manufacture of 100% recycled plastic ECOTRAX railroad ties. With intent to expand its output, Axion entered into a manufacturing agreement with Coll Materials at its Southwest location in June 2011.

In order to facilitate Axion’s annual production of about 200,000 ECOTRAX rail ties, the Waco-based production line of Coll Materials is being expanded. The production line will be functional by Q2, 2012.

Axion CEO and President, Steve Silverman said that the company’s rail business has been experiencing significant progress universally, and this new facility will furnish the increasing demand. Following this collaboration, Axion enhanced its rapport with Coll, with the latter operating to cater to the manufacturing requirements of the firm. With the advancement, the firm anticipates being quality oriented. This expansion facilitates recycling of approximately 37M lb of waste plastics, eliminating landfill accumulation.

According to Coll Materials’ CEO and President Brian Coll, the company’s recycling business is being improved with contract manufacturing. Operating with another green company, the company anticipates furnishing the demands and challenges of the products manufactured by Axion.

Axion ECOTRAX ties, manipulated with Axion’s patented formula, prove to be the ideal green solution for the rail industry. This durable product is capable of withstanding wet, extreme, and caustic environmental conditions.

Source: http://www.axionintl.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Axion and Coll Materials Increase Production Capabilities to Meet Demand for ECOTRAX Rail Ties. AZoBuild. Retrieved on November 23, 2024 from https://www.azobuild.com/news.aspx?newsID=14853.

  • MLA

    Scanlon, Joel. "Axion and Coll Materials Increase Production Capabilities to Meet Demand for ECOTRAX Rail Ties". AZoBuild. 23 November 2024. <https://www.azobuild.com/news.aspx?newsID=14853>.

  • Chicago

    Scanlon, Joel. "Axion and Coll Materials Increase Production Capabilities to Meet Demand for ECOTRAX Rail Ties". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14853. (accessed November 23, 2024).

  • Harvard

    Scanlon, Joel. 2019. Axion and Coll Materials Increase Production Capabilities to Meet Demand for ECOTRAX Rail Ties. AZoBuild, viewed 23 November 2024, https://www.azobuild.com/news.aspx?newsID=14853.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.